GENEVA, Nov. 24 -- HS DIAGNOMICS GMBH (SchloBstr. 11012163 Berlin) filed a patent application (PCT/EP2025/063229) for "KRAS Q16H SPECIFIC T CELL RECEPTORS AND USES THEREOF" on May 14, 2025. With publication no. WO/2025/238079, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HENNIG, Steffen (HS Diagnomics GmbHSchlossstrasse 11012163 Berlin)

Abstract: The invention relates to isolated T cell receptors specific for Q61H mutations in the KRAS cancer oncogene, and engineered cells expressing such T cell receptors. Further asp...